First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome

BMC Medical Genetics

Volumn 18, Issue 1, 2017, Pages

  Hugon Rodin, Justine ^a   Sonigo, Charlotte ^b,c   Gompel, Anne ^a   Dodé, Catherine ^d   Grynberg, Michael ^b   Binart, Nadine ^c   Beau, Isabelle ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Cochin Hospital ^*  (France)

Author keywords

CAMP; FSHR; Mutation; Spontaneous ovarian hyperstimulation syndrome

Indexed keywords

CYCLIC AMP; ESTRADIOL; FOLLITROPIN RECEPTOR; GONADORELIN AGONIST; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR; RECOMBINANT FOLLITROPIN;

ADULT; ANIMAL CELL; ARTICLE; CASE REPORT; CONFOCAL MICROSCOPY; COS-7 CELL LINE; CYTOPLASM; DNA SEQUENCE; ECHOGRAPHY; FEMALE; FOLLICULAR STIMULATING HORMONE RECEPTOR GENE; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HORMONAL CONTRACEPTION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LAPAROSCOPY; NON GESTATIONAL SPONTANEOUS OVARIAN HYPERSTIMULATION SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY HYPERSTIMULATION; OVARY TORSION; PATHOPHYSIOLOGY; PELVIC PAIN; SALPINGOOOPHORECTOMY; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MUTATION; SEQUENCE HOMOLOGY;

ADULT; AMINO ACID SEQUENCE; ANIMALS; CYTOPLASM; FEMALE; HUMANS; MUTATION; OVARIAN HYPERSTIMULATION SYNDROME; RECEPTORS, FSH; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 85018357009     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-017-0407-6     Document Type: Article

References (22)

1. Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol RBE. 2012;10:32.
2. Boothroyd C, Karia S, Andreadis N, Rombauts L, Johnson N, Chapman M, et al. Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol. 2015;55:523-34.
3. Panagiotopoulou N, Byers H, Newman WG, Bhatia K. Spontaneous ovarian hyperstimulation syndrome: case report, pathophysiological classification and diagnostic algorithm. Eur J Obstet Gynecol Reprod Biol. 2013;169:143-8.
4. Miras AD, Mogford JT, Wright J, Mendoza NN, Xekouki P, Lakhani A, et al. Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone. Lancet Lond Engl. 2015;385:392.
5. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med. 2003;349:760-6.
6. De Leener A, Caltabiano G, Erkan S, Idil M, Vassart G, Pardo L, et al. Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome. Hum Mutat. 2008;29:91-8.
7. De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G, et al. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab. 2006;91:555-62.
8. Vasseur C, Rodien P, Beau I, Desroches A, Gérard C, de Poncheville L, et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med. 2003;349:753-9.
9. Montanelli L, Delbaere A, Di Carlo C, Nappi C, Smits G, Vassart G, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 2004;89:1255-8.
10. Desai SS, Roy BS, Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reprod Camb Engl. 2013;146:R235-248.
11. Bramble MS, Goldstein EH, Lipson A, Ngun T, Eskin A, Gosschalk JE, et al. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing. Hum Reprod Oxf Engl. 2016;31:905-14.
12. Vannier B, Loosfelt H, Meduri G, Pichon C, Milgrom E. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry (Mosc). 1996;35:1358-66.
13. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 1998;102:1352-9.
14. Beau I, Groyer-Picard MT, Le Bivic A, Vannier B, Loosfelt H, Milgrom E, et al. The basolateral localization signal of the follicle-stimulating hormone receptor. J Biol Chem. 1998;273:18610-6.
15. Siegel ET, Kim H-G, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci Thousand Oaks Calif. 2013;20:211-33.
16. Di Carlo C, Savoia F, Fabozzi A, Gargano V, Nappi C. A case of ovarian torsion in a patient carrier of a FSH receptor gene mutation previously affected by spontaneous ovarian hyperstimulation syndrome. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2015;31:105-8.
17. Timossi C, Ortiz-Elizondo C, Pineda DB, Dias JA, Conn PM, Ulloa-Aguirre A. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor. Mol Cell Endocrinol. 2004;223:17-26.
18. Ulloa-Aguirre A, Uribe A, Zariñán T, Bustos-Jaimes I, Pérez-Solis MA, Dias JA. Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression. Mol Cell Endocrinol. 2007;260-262:153-62.
19. Banerjee AA, Mahale SD. Role of the Extracellular and Intracellular Loops of Follicle-Stimulating Hormone Receptor in Its Function. Front Endocrinol. 2015;6:110.
20. Duvernay MT, Zhou F, Wu G. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem. 2004;279:30741-50.
21. Zariñán T, Perez-Solís MA, Maya-Núñez G, Casas-González P, Conn PM, Dias JA, et al. Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys. Mol Cell Endocrinol. 2010;321:112-22.
22. Uchida S, Uchida H, Maruyama T, Kajitani T, Oda H, Miyazaki K, et al. Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome. PLoS One. 2013;8:e75478.